INSTITUT PASTEUR DE NOUVELLE-CALEDONIE

Their core work

Institut Pasteur de Nouvelle-Calédonie is a public health research institute based in Noumea, operating as part of the global Institut Pasteur network. Their core work is laboratory surveillance, field epidemiology, and experimental research on vector-borne diseases endemic to the Pacific region — particularly arboviruses such as Zika, Dengue, Chikungunya, and Rift Valley Fever, and the mosquito and insect species that transmit them. In H2020, they contributed field data, biological samples, and entomological expertise from a disease-endemic Pacific Island context that few European partners can replicate. They sit at the intersection of tropical medicine, vector biology, and public health response, offering access to real outbreak settings rather than laboratory simulations.

What they specialise in

How they've shifted over time

Both H2020 projects started within a 12-month window (2016–2017), making meaningful temporal evolution difficult to assess. That said, ZIKAlliance was an emergency response to a specific outbreak pathogen, while INFRAVEC2 represented a broader, infrastructure-building approach to all vector-borne diseases — suggesting a shift from crisis-reactive to systematic, long-term capacity work. The keyword data for ZIKAlliance contains a data artifact (a raw timestamp) rather than actual terms, so the early-period keyword analysis cannot be used reliably; the trend interpretation is based on project scope and timing alone.

Their trajectory points toward becoming a recognized Pacific node in EU-connected vector disease infrastructure — a role that would suit future One Health, climate-driven disease spread, or pandemic preparedness consortia.

How they like to work

IPNC has participated exclusively as a consortium partner across both H2020 projects, never in a coordinator role — consistent with their profile as a specialized field contributor embedded in large international networks. Despite only two projects, they accumulated 71 unique consortium partners across 25 countries, suggesting they join high-membership, globally distributed consortia rather than small bilateral collaborations. This makes them well-suited as a specialist node providing geographic and epidemiological access rather than as a project manager.

IPNC's 71 consortium partners across 25 countries — from just two projects — reflects participation in very large, internationally composed consortia. Their network skews toward European research institutions and public health agencies, bridged by Institut Pasteur's global connections, with IPNC itself anchoring the Pacific island dimension.

What sets them apart

IPNC offers something almost no European or mainland research institution can provide: direct, operational access to vector-borne disease outbreaks in the Pacific Island context, where Zika, Dengue, and Chikungunya have caused well-documented epidemics. As a member of the Institut Pasteur network, they come with institutional credibility, biosafety infrastructure, and established protocols that independent tropical institutes often lack. For consortia building toward WHO or One Health goals, they fill a geographic and epidemiological gap that is otherwise hard to source.

Highlights from their portfolio

• INFRAVEC2
  The largest of the two projects by funding (EUR 92,526) and scope, this Research Infrastructure action connects IPNC to a pan-European platform for vector-borne disease control — a strategic, long-term role rather than a one-off research contribution.
• ZIKAlliance
  Participation in a global Zika response alliance launched during the 2015–2016 outbreak emergency demonstrates that IPNC is called upon when real-world Pacific outbreak data is urgently needed by international consortia.